BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6990882)

  • 1. Defective polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis associated with a serum inhibitor.
    Hanlon SM; Panayi GS; Laurent R
    Ann Rheum Dis; 1980 Feb; 39(1):68-74. PubMed ID: 6990882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective serum chemotactic capacity in rheumatoid arthritis.
    Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
    Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directed migration of circulating polymorphonuclear leucocytes in patients with rheumatoid arthritis: a defect in the plasma.
    Walker JR; James DW; Smith MJ
    Ann Rheum Dis; 1979 Jun; 38(3):215-8. PubMed ID: 485575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of two in vitro methods for studying a defect in leucocyte movement in rheumatoid arthritis.
    Walker JR; Smith MJ; James DW
    Int Arch Allergy Appl Immunol; 1979; 59(3):343-8. PubMed ID: 447412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
    Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
    Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Bacteroides fragilis cellular components on chemotactic activity of polymorphonuclear leukocytes towards Escherichia coli.
    Namavar F; Verweij-Van Vught AM; Bal M; MacLaren DM
    J Med Microbiol; 1987 Sep; 24(2):119-24. PubMed ID: 3309320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tenoxicam on neutrophil chemotaxis in rheumatoid arthritis and healthy controls.
    Hascelik Z; Hascelik G; Celiker R; Ozalp M
    Clin Rheumatol; 1994 Mar; 13(1):98-102. PubMed ID: 8187453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of neutrophil chemotaxis in methotrexate-treated rheumatoid arthritis patients.
    O'Callaghan JW; Forrest MJ; Brooks PM
    Rheumatol Int; 1988; 8(1):41-5. PubMed ID: 3363283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis.
    Mowat AG; Baum J
    J Clin Invest; 1971 Dec; 50(12):2541-9. PubMed ID: 5156708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of treatment on the chemotaxis of polymorphonuclear neutrophils in rheumatoid arthritis].
    Youinou P; Lepoivre B; Mottier D; Le Goff P
    Rev Rhum Mal Osteoartic; 1985 Jun; 52(6):409-12. PubMed ID: 4048811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired interleukin-8-dependent chemotaxis by synovial fluid polymorphonuclear leukocytes in rheumatoid arthritis.
    Hashimoto H; Yamamura M; Nishiya K; Ota Z
    Acta Med Okayama; 1994 Aug; 48(4):181-7. PubMed ID: 7817772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of pregnancy serum on polymorphonuclear leukocyte chemotaxis.
    Takeuchi A; Persellin RH
    J Clin Lab Immunol; 1980 Mar; 3(2):121-4. PubMed ID: 7205931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring chemotaxis of polymorphonuclear leukocytes with the "sparse-pore" polycarbonate membrane in the Boyden chamber: chemotactic activity of rheumatoid synovial fluid.
    Bignold LP
    Arch Immunol Ther Exp (Warsz); 1992; 40(1):33-7. PubMed ID: 1485825
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutrophil functions in rheumatoid arthritis.
    Nada R; Datta U; Deodhar SD; Sehgal S
    Indian J Pathol Microbiol; 1999 Jul; 42(3):283-9. PubMed ID: 10862285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphonuclear leukocyte chemotaxis by mixed anaerobic and aerobic bacteria.
    Namavar F; Verweij-Van Vught AM; Vel WA; Bal M; MacLaren DM
    J Med Microbiol; 1984 Oct; 18(2):167-72. PubMed ID: 6387126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired polymorphonuclear leucocyte chemotaxis in rheumatoid arthritis.
    Goddard DH; Kirk AP; Kirwan JR; Johnson GD; Holborow EJ
    Ann Rheum Dis; 1984 Apr; 43(2):151-6. PubMed ID: 6324704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphonuclear chemotaxis: a further contribution to the study of the pathogenesis of nephrosis].
    Guerra A; Genova R; Chiossi C
    Pediatr Med Chir; 1982; 4(1-2):43-7. PubMed ID: 7050934
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.
    Lundin A; Håkansson L; Michaëlsson G; Venge P
    Arch Dermatol Res; 1987; 279(6):385-91. PubMed ID: 3674962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.